Americas Gold Nanoparticles Market Size is Expected to Reach USD 367.3 Million by 2030 | MRFR

Market Overview

The Americas Gold Nanoparticles Market was estimated at USD 696.6 million in 2017 and is expected to grow significantly over the forecast period, reaching USD 367.3 Million by 2030 at a CAGR of 17.4%. Gold nanoparticles are nanoparticles composed of an inner core of gold atoms encased in a protective stabilizing shell – often a combination of molecules and other atoms.

The Americas Gold Nanoparticles Market is projected to exhibit strong growth prospects in the coming years. During the forecast period, the demand for gold nanoparticles is expected to increase over 2030. The growing concerns about drug delivery, advances in nanotechnology, increasing applications in medical and healthcare industry are expected to be some of the major drivers contributing to the market growth of the Americas Gold Nanoparticles.

Industry Outlook

Gold nanoparticles have shaped the medical, healthcare, biological and diagnostics fields in the last decades. Gold nanoparticles have been used for the detection of various compounds such as ions, microorganisms, proteins, DNA and others. Gold nanoparticle can also be used for drug delivery, imaging, and sensing. The growing prevalence of cancer, the rising demand for nanotechnology and the developments in the medical & healthcare sector are few of the factors stimulating the Americas Gold Nanoparticles Market.

Market Segmentation

In the Americas, the gold nanoparticles market is segmented into submarkets defined by product type, application, and geography. The Americas Gold Nanoparticles Market is divided into many submarkets based on the shape of the particles, with spherical, cube-shaped, flower-shaped, rod-shaped, ring-shaped, and wire-shaped categories all present. The Market is segmented into many submarkets based on its final consumer, including the healthcare and medical sector, electronics, food and beverage, energy, and others. North America, Europe, Asia-Pacific, and the Rest of the Americas are the different segments that make up the Market.

Geographical Coverage

By region, the Americas Gold Nanoparticles Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the Americas. North America region is expected to account for the largest market share of the Americas due to the presence of a large number of pharmaceutical and healthcare companies engaged in developing novel drug delivery systems. The growing prevalence of cancer, the rising demand for nanotechnology, the developments in the medical & healthcare sector and the presence of major players in the region are key factors contributing to the market growth of the Americas.

Market Forecast

The Americas Gold Nanoparticles Market is poised for massive expansion. The rising demand for nanotechnology and its applications in the medical & healthcare industry is one of the key factors propelling the market growth of the Americas Gold Nanoparticles. The growing prevalence of cancer, the rise of personalised medicine, the increased investment in gold nanoparticle research and the increasing number of collaborations among partners are some of the other major factors contributing to the growth of the Market.

Explore In-depth Details: Americas Gold Nanoparticles Market Research Report

Companies Profiled

Some of the major players in the Americas Gold Nanoparticles Market include Nanopartz Inc., NanoHybrids, LLC, Bayer AG, Merck KGaA, Johnson & Johnson, Angstrom Advanced Inc., and Nanoshel LLC, among others.

Key findings

• The North America region is expected to account for the largest share of the Americas market due to the presence of a large number of pharmaceutical and healthcare companies.


• The growing prevalence of cancer, the rising demand for nanotechnology, the developments in the medical & healthcare sector, and the presence of major players in the region are key factors contributing to the market growth.


• Some of the major players in the Americas Gold Nanoparticles Market include Nanopartz Inc., NanoHybrids, LLC, Bayer AG, Merck KGaA, Johnson & Johnson, Angstrom Advanced Inc., and Nanoshel LLC, among others.